Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : The Microcap Kitchen: Stocks 5¢ to $5 -- Ignore unavailable to you. Want to Upgrade?

To: GARY P GROBBEL who wrote (59214)	12/4/2006 3:48:24 PM
From: GARY P GROBBEL	Read Replies (2) \| Respond to of 120415

EROX>..pegging this one at .90 for 2007 also. They now have Johnson and Johnson licensing their pheromone technology for $1.8m PLUS royalties....and cosmetic companies are intensely competitive...so I expect more licensing in 2007.......and that's not exclusive....plus their own revenues are rising AND they posted a profit 3rd qtr...very unusual for a biotech company...... PR NEWSWIRE) Human Pheromone Sciences Announces License Agreement Human Pheromone Sciences Announces License Agreement SAN JOSE, Calif., Aug. 21 /PRNewswire-FirstCall/ -- Human Pheromone Sciences, Inc. (OTC Bulletin Board: EROX) ("HPS" or "the Company") today announced the signing of a License Agreement with Personal Products Company, a division of McNeil-PPC., Inc. ("PPC") a Johnson & Johnson company. Under the terms of the Agreement, HPS granted PPC a license to certain HPS patents in exchange for an initial cash payment and future royalties on sales. The Company retains exclusive rights in several product fields and shares co-exclusive rights in other product areas, with the right to sublicense. "We are looking forward to working with PPC as they look to expand the use of the Company's patented technology," a spokesperson for HPS indicated. The Company confirmed that it continues to test additional types of mood-enhancing compounds that have shown significant promise in human testing, and will seek partners to bring these new compounds to market. Human Pheromone Sciences, Inc. is a technology-based company, whose proof of concept products included prestige-priced fragrances and toiletries and environmental products sold under the Natural Attraction(R), REALM(R), innerREALM(R) and EROX(R) trademarks. These products contain mood-enhancing compounds, whose efficacy has been validated at leading universities around the world, and whose use is covered under United States and foreign patents. The Company is also involved in research and product development efforts on new compounds that have been previously identified as stimulating the emotional centers of the human brain. Further information is available online =============== Aslo, their own revenues are rising...and they made a profit. AND there are only 4m shares out...price explosion due at some point. Go to their site and look into human pheromone science...very intersting stuff....a lot of douhg can be made here..and they have patents on it. Human Pheromone Sciences Announces Third Quarter Results Human Pheromone Sciences Announces Third Quarter Results SAN JOSE, Calif., Nov. 14 /PRNewswire-FirstCall/ -- Human Pheromone Sciences, Inc. (OTC Bulletin Board: EROX) ("HPS" or "the Company") today announced results for the third quarter ended September 30, 2006. Net revenues of $365,000, more than tripled the net revenues of $91,000 in the prior year period, and resulted in net income of $49,000 ($.01 per share) as compared with a net loss of $198,000 ($.05 per share) for the same period of 2005. For the nine months ended September 30, 2006, net revenues were $815,000, a 134% increase from the $348,000 reported in the prior year period, and resulted in a net loss of $177,000 ($.04 per share) as compared with a net loss of $727,000 ($.18 per share) for the same period of 2005. At September 30, 2006, the Company's cash and accounts receivable aggregated $2,027,000 as compared with $463,000 at December 31, 2005. The Company indicated that the $274,000 growth in revenue in the quarter was primarily attributable to a significant increase in pheromone purchases by the Company's largest customers in this area and $57,000 in revenue attributable to a Licensing Agreement signed by the Company in August of 2006. The balance of cash received by the Company under the License Agreement, $1,693,000 is reflected in the financial statements as deferred income, to be amortized over future quarters. "The increase in net revenues shows continued consumer acceptance of the efficacy of our currently patented human pheromone technology in the fragrance market, and new interest in its potential in additional consumer markets worldwide. In addition, we are pleased by the progress being made and third party interest in new technology being developed and tested by the Company," a spokesperson indicated.

To: GARY P GROBBEL who wrote (59214)	12/22/2006 3:04:00 PM
From: GARY P GROBBEL	Read Replies (1) \| Respond to of 120415

CVV>..this aspect alone could send this stock up into deep space but the seewt thing about CVV is you have growing revenue and real solid profits to round out the picture....their acq of First Nano was a master stroke by management: University of Cincinnati Researchers Grow Their Longest Carbon Nanotube Ever A nanospace race has raged to successfully grow a nanotube array suitable for many uses. And today a UC research team, in conjunction with First Nano, is ahead - by a thousandth of a hair. Date: 11/29/2006 By: Wendy Beckman Phone: (513) 556-1826 Other Contact: Vesselin Shanov, PhD Other Contact Phone: (513) 556-2461 Nanotechnology revolves around the creation of technology - films, materials, devices, applications and systems - on a scale of 1-100 nanometers. But what is a nanometer? A nanometer is one billionth of a meter or 40 billionths of an inch. A human hair is between 50 and 100 microns wide - and a micron is 1,000 nanometers. A DNA molecule is about 2 1/2 nanometers wide. A typical human hair is between 50,000 and 100,000 nanometers wide. So, we could stack at least 1000 nano-devices across the end of a human hair. The Largest of the Small It might sound like an oxymoron, but long nanotubes are critical to manufacturers and practitioners in such fields as transportation, defense, safety and medicine. Because of their increased surface area, large nanotube arrays offer improvements in sensors. Larger nanotubes can be "spun" - or suspended in an epoxy-like substrate - and used to strengthen materials used in airplanes, for example. Like your great-grandmother's yarn, the longer a continuous thread, the better. In -------------------------------------------------------------------------------- conjunction with First Nano (FN), a division of CVD Equipment Corporation, UC has grown an array on FN's EasyTube Carbon Nanotube system that is longer than 7 mm. "The harmonious combination of substrate, alloy catalyst and process conditions was found to consistently produce nanotube arrays more than 7 mm long" says Professor Vesselin Shanov, co-director of Smart Materials Nanotechnology Laboratory at the University of Cincinnati (UC). In recognition for its commitment to nanotechnology education at both the graduate and undergraduate level, UC is ranked #2 in the United States for nanotechnology education by Small Times magazine. "First Nano and UC have collaborated in the past and are planning on future collaboration to scale up production of nanotube arrays for applications that man has only dreamed of, like a super-strong cable for a space elevator and featherweight composite materials for sporting goods, aircraft structures, armor and many more uses." Leonard Rosenbaum, President and Chief Executive Officer of CVD Equipment Corporation states, "We look forward to continuing our relationship with the University of Cincinnati to bring this technology from the laboratory into full-scale production." Synthesis of Macro Scale Carbon Nanotube Arrays The recent breakthroughs at the University of Cincinnati and CVD Equipment Corporation (of Ronkonkoma, New York), have led to the growth of large carbon nanotube arrays. While individual carbon nanotubes are only 20 billionths of a meter in diameter, the array of carbon nanotubes grow as millimeter-long dense forests on centimeter-wide substrates. Years of research by UC's Shanov, Schulz and students Andrew Gorton and Yun YeoHeung led to the invention of the method for growing the large nanotube arrays. Researchers and engineers at CVD Equipment Corporation developed and built the equipment used to grow the large carbon nanotube arrays.